X0708 D LIVE 0002022416 Silexion Therapeutics Corp 12 ABBA HILLEL ROAD RAMAT GAN L3 ISRAEL 5250606 +972-3-756-4999 CAYMAN ISLANDS None Biomotion Sciences Corporation true 2024 Ilan Hadar c/o Silexion Therapeutics Corp 12 Abba Hillel Road Ramat Gan L3 ISRAEL 5250606 Executive Officer Director Mirit Horenshtein-Hadar c/o Silexion Therapeutics Corp 12 Abba Hillel Road Ramat Gan L3 ISRAEL 5250606 Executive Officer Ruth Alon c/o Silexion Therapeutics Corp 12 Abba Hillel Road Ramat Gan L3 ISRAEL 5250606 Director Ilan Levin c/o Silexion Therapeutics Corp 12 Abba Hillel Road Ramat Gan L3 ISRAEL 5250606 Director Avner Lushi c/o Silexion Therapeutics Corp 12 Abba Hillel Road Ramat Gan L3 ISRAEL 5250606 Director Shlomo Noy c/o Silexion Therapeutics Corp 12 Abba Hillel Road Ramat Gan L3 ISRAEL 5250606 Director Amnon Peled c/o Silexion Therapeutics Corp 12 Abba Hillel Road Ramat Gan L3 ISRAEL 5250606 Director Dror Abramov c/o Silexion Therapeutics Corp 12 Abba Hillel Road Ramat Gan L3 ISRAEL 5250606 Director Mitchell Shirvan c/o Silexion Therapeutics Corp 12 Abba Hillel Road Ramat Gan L3 ISRAEL 5250606 Executive Officer Biotechnology No Revenues 06b false 2025-08-01 false true true true false 0 H.C. Wainwright & Co., LLC 000000375 None None 430 Park Avenue 3rd Floor NEW YORK NY NEW YORK 10022 CT CONNECTICUT FL FLORIDA IL ILLINOIS KY KENTUCKY NY NEW YORK false 3597662 3597662 0 Form D covers new warrants issued 8/1/2025: investor warrants (304,212 at $11.32/share) and agent warrants (10,647 at $14.4625/share). Excludes exercise of warrants issued Jan 2025. Total offering amount equals exercise price of new warrants. false 11 140789 909500 7% cash fee + 1% mgmt. fee to H.C. Wainwright on warrant exercise proceeds. Finder's fees: $25,000 expense allowance, $50,000 legal/out-of-pocket expenses, & $15,950 clearing fees. HCW agent warrants instead included in Item 13. 0 Silexion Therapeutics Corp expects to use any proceeds from the future exercise of the new warrants for general corporate purposes. No proceeds are expected to be paid to executive officers, directors, or promoters. false Silexion Therapeutics Corp /s/ Ilan Hadar Ilan Hadar Chief Executive Officer 2025-08-11